Chris Danek

Your HealthTech product is solid, but you aren’t getting traction. Pilot stalls Failed to scale Uninterested clinicians Ghosted by administrators Founders, why why oh why is this happening to you? If you are building in HealthTech, You have to build something you know will either - fit seamlessly into the current workflow OR - disrupts a current broken workflow and builds it back with true effectiveness And you can only do this if you talk to clinicians Boots on the ground Taking care of patients Doing the admin tasks In the trenches Not their bosses Not their C-suite Not the crusty old RN or MD MBA who hasn’t done a set of vitals in 23 years (sorry) Not your college roommate or golfing buddy. It doesn’t have to be hard. It doesn’t have to break your budget. But you desperately need to validate your implementation to communicate value and drive adoption.

24

15 Comments

🩺 The rise of agentic AI in healthcare 🚀 Microsoft for Startups #Pegasus companies, Atropos Health, Autonomize AI, IgniteData and RAAPID INC are proving how autonomous AI can deliver real-world impact across #clinical, #operational and #research #workflows. 👉 Learn more about their work in my latest Technology Record article, https://lnkd.in/ei9yxxcK Graydon Hughes Ganesh Padmanabhan Tom Pauly Zach Taft, MBA Vikas Arora Michael Clark Derek Haynes Jared Prins Ran Wei Baker Microsoft for Healthcare #AutonomousAI #AgenticAI #AIinHealthcare #HealthcareOnLinkedIn #Innovation #MicrosoftforStartups #Payers #Providers #Pharma #AI

57

3 Comments

Three incredible days at #JPM2026. Same conversation with 10+ health system execs: "We're building our AI strategy. Evaluating vendors. Need to pick the right partners." This sounds familiar. 2009-2012: The EHR decision. After the HITECH Act, health systems spent 18-24 months evaluating Epic vs. Cerner. Consultants. Committees. RFPs. Multi-year implementations. The logic made sense: EHRs were monolithic platforms with huge switching costs. You had to get it right. 2025: The AI decision. I'm watching health systems do the same thing. "AI steering committees." "Strategic AI partner" RFPs. Trying to pick winners. But there's a critical difference: EHRs were a single, massive platform decision. AI in healthcare is dozens of different problems that need dozens of different solutions. Here's what health systems are missing: They're looking for "the AI vendor" when they should be building "an AI portfolio." There's no single AI platform that solves:   → Documentation burden (ambient notes) → Radiology throughput (workflow optimization) → Clinical trials matching → Revenue cycle optimization (across specialties) → Clinical decision support These are different problems. Different technologies. Different vendors. Different timelines. Some need FDA clearance and 24-month validations. Some can pilot in 90 days. Some integrate with Epic. Some replace parts of Epic. You can't solve all of these with one "strategic AI partnership”....no matter that Anthropic is saying right now. <ducks> The AI landscape is evolving too fast for monogamous vendor relationships. 6 months ago: GPT-4 for clinical documentation. Today: Ambient listening, agentic workflows, multimodal imaging analysis. 6 months from now: Something else entirely. That's why you need exposure across the whole landscape—not a bet on one vendor. The mistake I see health systems making: Approach 1: "Strategic Partner" Strategy Pick one AI vendor → Enterprise deal → 3-year commitment → Hope they solve everything Result: You're locked in. Technology moves on. You're stuck in vendor negotiations while competitors move faster. Approach 2: "Portfolio Strategy" Deploy capital across multiple companies → Take equity → Co-develop solutions → Maintain optionality Result: You capture upside. You shape products. You're first to new capabilities. You have relationships across the ecosystem. After 20 years building innovation platforms at JPMorgan, Mousse Partners, Blueprint Health, Junto Health, Atlantic Health: In fast-moving markets, portfolio strategies beat single-vendor bets. Healthcare AI is moving fast. The question isn't "Which AI vendor should we pick?" The question is: "How do we build an AI portfolio that gives us the most optionality" If you're thinking about this, let's talk. 📩 douglas.m.hayes@gmail.com ☎️ 215-620-2032 #healthcareAI #digitalhealth #venturecapital #innovation

293

25 Comments

Dual signals in global medtech innovation: FDA clears first at‑home brain stimulation device and AI smart dialysis manufacturing wins regulatory nod — a tectonic shift in therapeutic tech This week’s Medtech headlines spotlight regulatory validation of distributed therapeutic devices and AI‑enabled hardware moving toward scale. The U.S. FDA approved Flow Neuroscience’s FL‑100 — the first at‑home neurostimulation device for adults with moderate‑to‑severe depression — based on a mid‑stage study showing ~58% remission at 10 weeks, underscoring a broader shift of regulated therapy outside clinic walls. Simultaneously, Lords Mark Industries’ Renalyx AI‑based smart haemodialysis machines secured a national licence in India and CE marking, signaling global market access for AI‑driven critical care devices.   #MedTech #RegulatoryNews #AIinHealthcare #Innovation https://lnkd.in/gimCRHFf

51

Nice overview of the Rock Health Q3 report. So far in 2025, digital health funding is split between 19 megarounds of over $100 million and a low number of mid-stage Series B raises. The largest share of funding continues to go to startups focused on healthcare workflow and infrastructure.

6

This excellent article explores how consumer #technology is increasingly serving as accessible #healthcare tools for #aging populations and those with #disabilities. The author, highlights several breakthrough developments: Apple AirPods now function as FDA-authorized over-the-counter #hearingaids for mild to moderate hearing loss at a fraction of traditional costs, while also offering real-time translation capabilities. Visual assistance has advanced through smartphone apps like iPhone's Magnifier with Door Detection and Point and Speak features, plus Google’s #AI -powered Lookout app that provides detailed image descriptions. The #diabetes management landscape has transformed with over-the-counter continuous glucose monitors from companies like Dexcom and Abbott, allowing millions of Americans with diabetes or pre-diabetes to track their glucose levels without prescriptions. Research supports these innovations' health benefits, with studies showing that treating hearing loss can slow cognitive decline in #olderadults. For #entrepreneurs, this presents significant opportunities in developing affordable, consumer-friendly #medicaldevices that bypass traditional #health barriers. The success of repurposing existing technology (like AirPods) for medical use, the growing over-the-counter device market, and the integration of AI for accessibility features represent lucrative areas for innovation. Entrepreneurs can focus on creating solutions that transform everyday #consumerelectronics into health management tools, particularly targeting the massive aging population and the estimated 2.5 billion people projected to have hearing loss by 2050. Thoughts appreciated! #entrepreneurship #jtbd #business #investment #ehealth #mhealth #healthtech #seniors #populationhealth #consumerhealth https://lnkd.in/gunz-eZN

12

7 Comments